Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The most common reports are injection site redness, slight swelling, and occasional bruising
Statements about average outcomes reference published clinical trial data and patient-reported experiences, which may differ from individual results
Their high viscosities (measure of a liquids thickness) and effects on intestinal motility may slow or limit macronutrient uptake
The other is preservative-free
Randomization was conducted using an interactive web response system, assigning participants in a 6:1 ratio to one of several treatment arms: once-weekly subcutaneous Cagrilintide administered in doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo
